Unlocking the Origins of ALS Through Large-Scale Patient Data @EverythingALS
Unlocking the Origins of ALS Through Large-Scale Patient Data  @EverythingALS
Uploaded April 2026 | Updated November 2026, 2 days ago
We are excited to bring you a new episode of #ExpertTalk by EverythingALS.

In this session, we are joined by Dr. Jack Humphrey, PhD, Assistant Professor in the Department of Neuroscience at the Icahn School of Medicine at Mount Sinai, for an in-depth discussion on how large-scale patient data is transforming our understanding of ALS.

Dr. Humphrey explores how integrating genetics, functional genomics, and real-world patient data is helping researchers uncover the biological mechanisms that drive ALS and related neurodegenerative diseases. He explains how advances in computational biology and access to large, collaborative datasets are allowing scientists to move beyond isolated findings and begin identifying broader patterns across diverse patient populations.

Throughout the discussion, Dr. Humphrey highlights the importance of global collaboration between researchers, clinicians, and the ALS community. He shares how post-mortem tissue analysis, genomic sequencing, and AI-driven approaches are being used together to better understand disease origins, progression, and potential therapeutic targets.

In this talk, we cover:
• How large-scale patient datasets are advancing ALS research
• The role of genetics and molecular pathways in disease development
• Why collaboration across institutions and countries is critical
• How AI and computational tools are accelerating discovery
• The challenges of working with complex, real-world data
• Emerging insights into ALS and related neurodegenerative diseases

This conversation underscores the growing role of data-driven science in ALS research. By combining patient experience with cutting-edge technology, researchers are building a more complete picture of the disease and opening new pathways toward meaningful treatments.

📲 Download the EverythingALS App
• Google Play: bit.ly/4nXqIYy
• App Store: bit.ly/42tPBmh

Follow EverythingALS:
► Website: everythingals.org
► X: https://x.com/everything_als
► LinkedIn: linkedin.com/everythingals
► Facebook: facebook.com/EverythingALS
► Subscribe for more Expert Talks: youtube.com/c/everythingals

#ExpertTalk #EverythingALS #ALSResearch #ALSCommunity #NeurodegenerativeDisease #ALSScience #ALSData #BigData #ALSAdvocacy #ALSUpdates #ALSExperts #CollaborativeScience

🔔 If you are passionate about advancing ALS research and understanding, like, subscribe, and turn on notifications.

Sharing this episode helps expand awareness and keeps important scientific conversations moving forward.
Unlocking the Origins of ALS Through Large-Scale Patient DataBuilding Stronger Research Through CollaborationClenbuterol for ALS: Findings from an Open Label TrialImplantable BCI Technology - The Road to Access by Precision Neuroscience, Blackrock and CognixionStories and Innovation in ALS Episode #11:  Dying Out Loud with Dave Warnock and Bevin Jett2025: New therapies and approaches in ALS : gene, small molecules, repair, and moreDr. Olga Uspenskaya-Cadoz and Dr. James Berry discuss PIONEER-ALS and TDP-43 research.Health Insurers Delay or Deny Home Ventilation. What Can Be Done? by Dr. John Hansen-Flaschen#ExpertTalk: Targeting an Endogenous Retrovirus as a Therapeutic Approach to ALSEverythingALS Radcliff Study IntroductionNeuroSense Therapeutics Reports Positive Results from Stage III ALS Biomarker StudyHappy birthday Peter - July 2nd 2022
Everything ALS |

Unlocking the Origins of ALS Through Large-Scale Patient Data

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER